Tuesday, March 21, 2023
WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.
Professor of Rheumatology
Amsterdam University Medical Centers
Chief, Department of Rheumatology and Clinical Immunology
Director
Amsterdam Rheumatology Center (ARC)
Amsterdam, the Netherlands
Associate Professor in Allergy and Clinical Immunology
Department of Internal Medicine
Erasmus MC
Rotterdam, the Netherlands
Non-US Physicians - maximum of 0.50 CPD
This educational activity is intended for a European audience of primary care physicians, rheumatologists, and pediatricians.
The goal of this activity is for learners to be better able to discuss the concept of autoinflammation, similarities and differences between autoinflammatory and autoimmune diseases, signaling pathways of autoinflammatory syndromes, definition and classification, clinical phenotypes of commonly encountered autoinflammatory diseases, and the clinical approach to differentiate autoinflammation from autoimmunity.
Upon completion of this activity, participants will:
WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.
Professor of Rheumatology
Amsterdam University Medical Centers
Chief, Department of Rheumatology and Clinical Immunology
Director
Amsterdam Rheumatology Center (ARC)
Amsterdam, the Netherlands
Associate Professor in Allergy and Clinical Immunology
Department of Internal Medicine
Erasmus MC
Rotterdam, the Netherlands
The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information about your
eligibility to claim credit, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must
complete the activity online during the credit eligibility period that is noted on the title page.
Follow these steps to claim a credit certificate for completing this activity:
We encourage you to complete an Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CPD Released: 5/27/2022
Valid for credit through: 5/27/2023
processing....
